Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
2621
-
2622
-
2623
-
2624
-
2625
-
2626
-
2627
-
2628
-
2629
-
2630
-
2631
Vps34 supports Treg maintenance in lymphoid and non-lymphoid tissues.
Published 2025“…(<b>I</b>) Quantification of Bim/Mcl1 (left) and Bim/Bcl2 (right) ratios (based on gMFIs) from TCRβ<sup>+</sup>CD4<sup>+ </sup>Foxp3<sup>+ </sup>CD44<sup>low</sup>CD62L<sup>high</sup> cTregs or TCRβ<sup>+</sup>CD4<sup>+ </sup>Foxp3<sup>+ </sup>CD44<sup>high</sup>CD62L<sup>low</sup> eTregs derived from the spleen of control (<i>n</i> = 19) or <i>Foxp3</i><sup>Cre</sup><i>Pik3c3</i><sup>fl/fl</sup> (<i>n</i> = 17) mixed BM chimera mice. gMFI, geometric mean fluorescence intensity. Data are shown as mean ± s.e.m. …”
-
2632
-
2633
-
2634
-
2635
-
2636
Chromatin accessibility analysis of perinatal Vps34-deficient Tregs.
Published 2025“…Relative (normalized to average control in each experiment) fold-change comparisons between genotypes in each cell type are shown in bold (<b>A</b>, <b>B</b>). Data are shown as mean ± s.e.m. (<b>A</b>, <b>B</b>). Two-tailed Student <i>t</i> test (<b>A</b>, <b>B</b>, <b>I</b>), Benjamini–Hochberg test (<b>C</b>), Wilcoxon rank-sum test (<b>G</b>), Fisher’s exact tes<i>t</i> (<b>H</b>), or binomial test (<b>J</b>); NS, not significant. …”
-
2637
Atg14 plays a cell-intrinsic role in orchestrating eTreg survival but not terminal differentiation.
Published 2025“…Jun/Fos transcription factors with predicted decreased activity in Atg14-deficient versus control eTregs are labeled. …”
-
2638
-
2639
-
2640